Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H18N2 |
Molecular Weight | 238.3275 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC1CC2=CC=CC=C2N(C)C3=C1C=CC=C3
InChI
InChIKey=YXVZOBVWVRFPTE-UHFFFAOYSA-N
InChI=1S/C16H18N2/c1-17-14-11-12-7-3-5-9-15(12)18(2)16-10-6-4-8-13(14)16/h3-10,14,17H,11H2,1-2H3
Molecular Formula | C16H18N2 |
Molecular Weight | 238.3275 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Metapramine is a tetracyclic antidepressant available in tablet and injectable form. It is claimed to have an antidepressant effect and is useful in all types of depression. Metapramine is a low-affinity antagonist of the NMDA receptor complex channel. Its acting as a norepinephrine reuptake inhibitor without affecting the reuptake of serotonin and dopamine. Quick acting, metapramine has a very interesting peculiarity: its large tolerance, which seems to be related to a no-anticholinergic effect. Metapramine could be indicated for correction of extra-pyramidal side effects induced by neuroleptics or observed in parkinsonism.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1907608 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9076749 |
1.8 µM [IC50] | ||
Target ID: GO:0051620 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3017518 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:34:25 GMT 2023
by
admin
on
Fri Dec 15 17:34:25 GMT 2023
|
Record UNII |
303954M7YF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m7271
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | Merck Index | ||
|
3673
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | |||
|
1719
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | |||
|
21730-16-5
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | |||
|
C87617
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | |||
|
SUB08814MIG
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | |||
|
303954M7YF
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | |||
|
100000081217
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106919
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | |||
|
C012677
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | |||
|
65700
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | |||
|
DTXSID60865011
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY | |||
|
Metapramine
Created by
admin on Fri Dec 15 17:34:25 GMT 2023 , Edited by admin on Fri Dec 15 17:34:25 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |